U.S. markets close in 2 hours 55 minutes
  • S&P 500

    3,440.32
    -2.80 (-0.08%)
     
  • Dow 30

    28,251.34
    -57.45 (-0.20%)
     
  • Nasdaq

    11,493.61
    -22.89 (-0.20%)
     
  • Russell 2000

    1,608.94
    -8.77 (-0.54%)
     
  • Crude Oil

    39.92
    -1.78 (-4.27%)
     
  • Gold

    1,928.40
    +13.00 (+0.68%)
     
  • Silver

    25.19
    +0.22 (+0.86%)
     
  • EUR/USD

    1.1879
    +0.0051 (+0.43%)
     
  • 10-Yr Bond

    0.8060
    +0.0090 (+1.13%)
     
  • GBP/USD

    1.3167
    +0.0220 (+1.70%)
     
  • USD/JPY

    104.4500
    -1.0200 (-0.97%)
     
  • BTC-USD

    12,822.12
    +1,765.12 (+15.96%)
     
  • CMC Crypto 200

    256.95
    +12.06 (+4.92%)
     
  • FTSE 100

    5,776.50
    -112.72 (-1.91%)
     
  • Nikkei 225

    23,639.46
    +72.42 (+0.31%)
     

Enzo Biochem: Fiscal 4Q Earnings Snapshot

·1 min read

NEW YORK (AP) _ Enzo Biochem Inc. (ENZ) on Tuesday reported a loss of $3.3 million in its fiscal fourth quarter.

On a per-share basis, the New York-based company said it had a loss of 7 cents.

The life sciences and biotechnology company posted revenue of $19.5 million in the period.

For the year, the company reported a loss of $28.5 million, or 60 cents per share, swinging to a loss in the period. Revenue was reported as $76 million.

In the final minutes of trading on Tuesday, the company's shares hit $2.60. A year ago, they were trading at $3.32.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ENZ at https://www.zacks.com/ap/ENZ